Skip to content
★ Sign in to follow
ML

Michael Lytton

Executive
Patheon N.V.Biogen Inc.Patheon Inc
Total declarations
16
Companies
3
▲ Purchases (8 ops.)
€265k
▼ Sales (0 ops.)
—

Latest filing published 22 Jul 2016 for Patheon N.V..

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Michael Lytton: trading record in brief

This profile gathers the share dealings of Michael Lytton across 3 companies, led by Patheon Inc, Biogen Inc. and Patheon N.V. In total, 16 filings cover trades dated from 2 March 2010 to 20 July 2016.

On the market, this insider has only ever bought: 8 purchases, €265k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants and 2 option exercises.

In size, the median ticket on the buying side is €29k.

The newest entry dates from 22 July 2016: a share grant, in Patheon N.V. The clock since the last published purchase (16 January 2013) now reads 5,044 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael Lytton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    EVP, Corp Development & StrtgyExecutivesPatheon N.V.
    0SEC
    227,201 shares0Restricted Stock Units (Ordinary Shares)SEC:0001209191-16-133761:0
  • ●
    EVP Corp Dev & Strategy and GCExecutivesPatheon Inc
    4M USD0SEC
    379,030 shares@ US$9.32Restricted Voting SharesSEC:0001181431-14-012457:0
  • ◇
    EVP Corp Dev & Strategy and GCExecutivesPatheon Inc
    160,800 USD0SEC
    80,000 shares@ US$2.01Restricted Voting SharesSEC:0001181431-13-042372:0
  • ▲
    EVP Corp Dev & Strategy and GCExecutivesPatheon Inc
    49,784 USD0SEC
    12,540 shares@ US$3.97Restricted Voting SharesSEC:0001181431-13-003336:0
    Canonical exit: 14 Apr 2013 (T+90)
  • ◇
    EVP Corp Dev & Strategy and GCExecutivesPatheon Inc
    169,600 USD0SEC
    80,000 shares@ US$2.12Restricted Voting SharesSEC:0001181431-13-002035:0
  • ◆
    EVP Corp Dev & Strategy and GCExecutivesPatheon Inc
    48,775 USD0SEC
    15,290 shares@ US$3.19Restricted Voting SharesSEC:0001181431-13-000821:0
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    115,000 USD0SEC
    100,000 shares@ US$1.15Restricted Voting SharesSEC:0001181431-11-061951:0
    Canonical exit: 22 Mar 2012 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    24,530 USD0SEC
    11,000 shares@ US$2.23Restricted Voting SharesSEC:0001181431-11-038094:0
    Canonical exit: 20 Sept 2011 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    42,714 USD0SEC
    18,900 shares@ US$2.26Restricted Voting SharesSEC:0001181431-11-038094:1
    Canonical exit: 21 Sept 2011 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    40,544 USD0SEC
    18,100 shares@ US$2.24Restricted Voting SharesSEC:0001181431-11-037731:0
    Canonical exit: 18 Sept 2011 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    18,160 USD0SEC
    8,000 shares@ US$2.27Restricted Voting SharesSEC:0001181431-11-037731:1
    Canonical exit: 19 Sept 2011 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    16,875 USD0SEC
    7,500 shares@ US$2.25Restricted Voting SharesSEC:0001181431-11-037490:0
    Canonical exit: 15 Sept 2011 (T+90)
  • ▲
    EVP CORPORATE DEVELOPMENT & STExecutivesPatheon Inc
    56,508 USD0SEC
    27,700 shares@ US$2.04Restricted Voting SharesSEC:0001181431-11-037199:0
    Canonical exit: 13 Sept 2011 (T+90)
  • ◆
    EVP Corporate & Business DevelExecutivesBiogen Inc.
    0SEC
    10,499 shares0Common StockSEC:0001127602-10-007464:0
  • ◆
    EVP Corporate & Business DevelExecutivesBiogen Inc.
    63,729 USD0SEC
    1,112 shares@ US$57.31Common StockSEC:0001127602-10-007464:1
  • ◆
    EVP Corporate & Business DevelExecutivesBiogen Inc.
    64,359 USD0SEC
    1,123 shares@ US$57.31Common StockSEC:0001127602-10-007464:2

16 of 16 declarations